Literature DB >> 26651250

Early esophageal cancer screening in China.

Qin-Yan Gao1, Jing-Yuan Fang2.   

Abstract

In China, the incidence of esophageal cancer (EC) and its related mortality are high. Screening strategies aiming at early diagnosis can improve the prognosis. Researches on detection of early EC, especially in China are reviewed. Compared to esophageal balloon cytology or routine endoscopy, chromoendoscopy with Lugol's staining and biopsy appears to be the gold standard for early EC diagnosis in China today. Narrow-band imaging endoscopy, Confocal Laser endomicroscopy and other novel diagnostic approaches are more and more widely used in developed urban areas, but cost and lack of essential training to the endoscopists have made their use limited in rural areas. No specific biomarkers or serum markers were strongly commended to be used in screening strategies currently, which need to be evaluated in future. Trials on organized screening have been proposed in some regions of china with high disease prevalence. Screening in these areas has been shown to be cost effective.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  China; Esophageal cancer; Screening

Mesh:

Year:  2015        PMID: 26651250     DOI: 10.1016/j.bpg.2015.09.018

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  18 in total

1.  Epigallocatechin-3-gallate inhibits growth and induces apoptosis in esophageal cancer cells through the demethylation and reactivation of the p16 gene.

Authors:  Jianchao Meng; Qiang Tong; Xiaobo Liu; Zongtao Yu; Jicai Zhang; Bo Gao
Journal:  Oncol Lett       Date:  2017-05-25       Impact factor: 2.967

2.  Tonglian Decoction () arrests the cell cycle in S-phase by targeting the nuclear factor-kappa B signal pathway in esophageal carcinoma Eca109 cells.

Authors:  Yong-Sen Jia; Xue-Qin Hu; Ji-An Li; Szasz Andras; Gabriella Hegyi; Bing-Sheng Han
Journal:  Chin J Integr Med       Date:  2016-03-05       Impact factor: 1.978

Review 3.  The BRAF activated non-coding RNA: A pivotal long non-coding RNA in human malignancies.

Authors:  Xiu-Fen Liu; Ji-Long Hao; Tian Xie; Om Prakash Pant; Cheng-Bo Lu; Cheng-Wei Lu; Dan-Dan Zhou
Journal:  Cell Prolif       Date:  2018-02-27       Impact factor: 6.831

Review 4.  Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer.

Authors:  Dan-Dan Zhou; Xiu-Fen Liu; Cheng-Wei Lu; Om Prakash Pant; Xiao-Dong Liu
Journal:  Cell Prolif       Date:  2017-10-12       Impact factor: 6.831

5.  Endoscopic resections for superficial esophageal squamous cell epithelial neoplasia: focus on histological discrepancies between biopsy and resected specimens.

Authors:  Lang Yang; Hua Jin; Xiao-Li Xie; Yang-Tian Cao; Zhen-Hua Liu; Na Li; Peng Jin; Yu-Qi He; Jian-Qiu Sheng
Journal:  BMC Gastroenterol       Date:  2021-03-09       Impact factor: 2.847

Review 6.  Inhibitory Effects of (-)-Epigallocatechin-3-gallate on Esophageal Cancer.

Authors:  Liu-Xiang Wang; Yun-Long Shi; Long-Jie Zhang; Kai-Rong Wang; Li-Ping Xiang; Zhuo-Yu Cai; Jian-Liang Lu; Jian-Hui Ye; Yue-Rong Liang; Xin-Qiang Zheng
Journal:  Molecules       Date:  2019-03-08       Impact factor: 4.411

7.  Development of a clinical score to distinguish malignant from benign esophageal disease in an undiagnosed patient population referred to an esophageal diagnostic assessment program.

Authors:  Negar Ahmadi; Lawrence Mbuagbaw; Waël C Hanna; Christian Finley; John Agzarian; Chuck K Wen; Michal Coret; Colin Schieman; Yaron Shargall
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

8.  Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma.

Authors:  Xiangyang Yu; Rusi Zhang; Tianzhen Yang; Mengqi Zhang; Kexing Xi; Yongbin Lin; Yingsheng Wen; Gongming Wang; Zirui Huang; Xuewen Zhang; Lanjun Zhang
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

9.  Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002-2011).

Authors:  Lan-Wei Guo; Hui-Yao Huang; Ju-Fang Shi; Li-Hong Lv; Ya-Na Bai; A-Yan Mao; Xian-Zhen Liao; Guo-Xiang Liu; Jian-Song Ren; Xiao-Jie Sun; Xin-Yu Zhu; Jin-Yi Zhou; Ji-Yong Gong; Qi Zhou; Lin Zhu; Yu-Qin Liu; Bing-Bing Song; Ling-Bin Du; Xiao-Jing Xing; Pei-An Lou; Xiao-Hua Sun; Xiao Qi; Shou-Ling Wu; Rong Cao; Li Lan; Ying Ren; Kai Zhang; Jie He; Jian-Gong Zhang; Min Dai
Journal:  Chin J Cancer       Date:  2017-09-07

10.  Factors relevant to the prognosis of patients with esophageal cancer who received intensity-modulated radiotherapy.

Authors:  Hongmei Yin; Duojie Li; Chaomang Zhu; Mingxi Wang; Nannan Wei
Journal:  Thorac Cancer       Date:  2018-08-01       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.